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E2F DNA-binding activity in vivo is due to heterodimer formation between members of the E2F and DP transcription
factor families. The ability of these heterodimers to serve as transcriptional regulators is modulated by complex formation
with additional proteins such as the products of the retinoblastoma gene and the adenovirus E4 ORF 6/7. Each of the E2F
family members cloned to date contains a highly conserved region of unknown function, termed the marked box, which lies
between their DNA binding and transactivation domains. Mutational analysis showed that the marked box contributed to
the recognition of E2F family members by the E4 ORF 6/7 protein in vitro and in vivo. q 1996 Academic Press, Inc.
INTRODUCTION et al., 1992; Mudryj et al., 1991; Pagano et al., 1992;
Shirodkar et al., 1992). The ability of p107 to bind to cyclin
E2F was initially identified as a cellular DNA-binding
A and E is mediated by a ‘‘spacer’’ element found within
activity capable of interacting with the adenovirus E2
its E2F binding domain (Ewen et al., 1992; Faha et al.,
promoter (Kovesdi et al., 1986a,b). Subsequently, poten-
1992). A cDNA for a third pRB-like protein, p130, has
tial E2F binding sites were identified in the promoters of
recently been cloned and appears to bind to E2F in G0/
a number of cell growth regulatory genes. Among these
G1 (Cobrinik et al., 1993).
are the genes encoding DHFR, c-myc, b-myb, DNA poly-
Several unrelated DNA tumor viruses encode onco-merase a, thymidine kinase, thymidylate synthase, cdc2,
proteins which can disrupt the binding of E2F by pRB,and cyclin A (Blake and Azizkhan, 1989; Dalton, 1992;
and pRB-like proteins such as p130 and p107, therebyHamel et al., 1992; Hiebert et al., 1991; Lam and Watson,
generating ‘‘free’’ E2F. These include the adenovirus E1A1993; Means et al., 1992; Moberg et al., 1992; Mudryj et
protein, the SV40 and polyoma T antigens, and the high-al., 1990; Nevins, 1992; Pearson et al., 1991; Thalmeier
risk human papillomavirus E7 proteins (Nevins, 1992).et al., 1989; Yamamoto et al., 1994). Experiments per-
Indirect evidence suggests that E2F activity is repressedformed to date suggest that, at least in some contexts,
by pRB, and perhaps p107, whereas ‘‘free’’ E2F appearsE2F sites are both necessary and sufficient to render
to be transcriptionally active (Arroyo and Raychaudhuri,transcription cell cycle dependent (Farnham et al., 1993;
1992; Beijersbergen et al., 1994; Ginsberg et al., 1994;Hsiao et al., 1994; Johnson et al., 1994; Neuman et al.,
Hiebert et al., 1992; Nevins, 1992; Schwarz et al., 1993;1994; Nevins, 1992).
Smith and Nevins, 1995; Weintraub et al., 1992; ZamanianE2F activity appears to be regulated, in part, through
and La Thangue, 1992; Zhu et al., 1993). To date, allspecific protein–protein interactions. The appearance of
naturally occuring, loss of function, pRB mutations impairthese complexes is, in turn, cell-cycle regulated. For ex-
its ability to bind to, and thus regulate, E2F (Booksteinample, E2F is found in association with the product of
et al., 1990; Horowitz et al., 1990, 1989; Kaye et al., 1990;the retinoblastoma gene (pRB) during G1, and perhaps
Scheffner et al., 1991; Shew et al., 1990). Furthermore, inS phase (Mudryj et al., 1991; Nevins, 1992; Shirodkar et
model systems, the ability of fragments of pRB to sup-al., 1992). A second protein with structural similarity to
press cell growth is tightly linked to their ability to bindpRB, p107, forms ternary complexes with E2F and cyclin/
to E2F (Ewen et al., 1993; Goodrich et al., 1991; Hiebert,cdk complexes. Specifically, in late G1, p107 forms com-
1993; Hiebert et al., 1992; Qian et al., 1992; Qin et al.,plexes with E2F, cyclin E, and cdk2, whereas in S phase
1992; Zhu et al., 1993).it binds to E2F, cyclin A, and cdk2 (Bandara and La
During adenoviral infection, the production of E1A isThangue, 1991; Cao et al., 1992; Devoto et al., 1992; Lees
thought to liberate E2F from control by RB-like proteins
(Nevins, 1992). A second viral protein, encoded by E4
1 To whom correspondence and reprint requests should be ad-
ORF 6/7, can form complexes with, and stabilize, E2Fdressed at Division of Neoplastic Disease Mechanisms, Dana-Farber
bound to the E2F double sites found in the adenovirusCancer Institute, 44 Binney St., Boston, MA 02115. Fax: (617) 632-4381.
E-mail: KAELIN@CISVX3.DFCI.HARVARD.EDU. E2 promoter (Huang and Hearing, 1989; Marton et al.,
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1990; Neill et al., 1990). The recruitment of E2F to the transfection. CaCl2 (0.5 ml, 0.5 M) was added to 0.5 ml
of ddH2O containing 24 mg of cesium chloride-bandedE2 promoter by E4 ORF 6/7 appears to depend on the
presence of two E2F DNA-binding sites with proper ori- DNA. This solution was then added dropwise to 1 ml
21 N-2-hydroxyethylpiperazine-N *-2-ethanesulfonic acidentation and spacing (Hardy et al., 1989; Hardy and
Shenk, 1989; Raychaudhuri et al., 1990). To date, no cellu- (HEPES)-buffered saline (21 HBS; 280 mM NaCl, 50 mM
HEPES (free acid), 1.5 mM Na2 HPO4). The calcium phos-lar promoter has been identified which can likewise sup-
port the formation of a stable E4–E2F–DNA complex, phate-DNA precipitates were allowed to form for 15 min
at room temperature, at which point they were addedraising the possiblity that E4 has evolved to specifically
target free E2F to a viral gene. dropwise to the cells. Approximately 16 hr later cells
were washed once with phosphate-buffered saline (PBS)A cDNA encoding a protein with E2F-like properties,
called E2F1, was independently isolated by several and were refed with 10 ml of fresh medium. Cells were
harvested 24 hr later.groups (Helin et al., 1992; Kaelin et al., 1992; Shan et al.,
1992). E2F1 contains an N-terminal domain which can
bind specifically to canonical E2F DNA-binding sites and Plasmid construction
a C-terminal transactivation domain. Within the latter is
nested an 18-residue colinear sequence which mediates Plasmids pRcCMV HA-E2F1, pcDNA DP-1, and
pRcCMV T7-DP-1 were kindly provided by W. Krek andbinding to pRB (Helin et al., 1992). pRB can suppress the
ability of E2F1 to transactivate by virtue of direct binding S. Shirodkar. pGEM E4 (orf 6/7), pGEM E4D13/14, pCMV
E4 (orf 6/7), and pCMV E4D14/15 were kindly providedto this region (Flemington et al., 1993; Hagemeier et al.,
1993; Helin et al., 1993). Conversely, overexpression of by J. Nevins (56, 57). The cDNAs for E2F2 and E2F3 were
kindly provided by J. Lees and E. Harlow and subclonedE2F1 can overcome the ability of pRB to induce a G1
arrest in RB0/0 cells (Qin, 1995; Zhu et al., 1993). cDNAs by W. Krek to create the plasmids pRcCMV HA-E2F2 and
pRcCMV HA-E2F3. pcDNA3 E2F5 was kindly provided byfor additional E2F family members (E2F2, E2F3, E2F4,
E2F5) have now been cloned (Beijersbergen et al., 1994; Claude Sardet. The E2F5 cDNA was excised as a BamHI/
XbaI fragment and subcloned into the pcDNA1 HA vector.Dynlacht et al., 1994; Ginsberg et al., 1994; Hijmans et
al., 1995; Ivey-Hoyle et al., 1993; Lees et al., 1993; Ohtani To make the E2-luciferase reporter plasmid (pGL2-
E2pro), the sequence between 085 and /30 of the ade-and Nevins, 1994; Sardet et al., 1995). Furthermore, it is
now clear that E2F family members bind to DNA in vivo novirus E2a upstream region was amplified by polymer-
ase chain reaction (PCR) using the oligonucleotides: 5*as heterodimers with members of the DP family of DNA-
binding proteins (Bandara et al., 1993; Helin et al., 1993; CCG GTA CCC TAG ACG CTC GAG ATG ACG T 3* and
5* GCC CAA GCT TGA TCA TGA TCA GCT TCG GCGHuber et al., 1993; Krek et al., 1993).
We have shown previously that, E4, produced as a CA 3*. The PCR product was digested with KpnI and
HindIII and subcloned into pGL2-Basic (Promega). Therecombinant protein, can bind to E2F1 obtained from
crude cell extracts (Kaelin et al., 1992). Here we have E2F1 cDNAs encoding E2F1(1–287), E2F1(1–292),
E2F1(1–297), E2F1(1–302), and E2F1(1–307) were gen-attempted to characterize the interaction of E4 and
cloned members of the E2F family in greater biochemical erated by site-directed mutagenesis (Bio-Rad Mutagene)
using oligonucleotides which introduced a TGA codonand functional detail. We found that a domain of pre-
viously unknown function (the ‘‘marked box’’) (Ginsberg at the desired sites in E2F1 and single-stranded DNA
prepared from pSG5-E2F1 (Qin et al., 1995). For the trun-et al., 1994; Lees et al., 1993) shared by the E2F family
members is required for E4 binding. This observation cation mutants HA-E2F1 1–311 and HA-E2F1 1–283,
pRcCMV HA-E2F1 was linearized with either BbsI orraises the possibility that this domain normally interacts
with cellular ‘‘E4-like’’ proteins. Such proteins might, for BglII, respectively, and the linearized DNA template was
then translated in vitro (T7 TNT coupled transcription/example, play roles in determining the binding site speci-
ficity of E2F containing heterodimers and/or modulate translation system, Promega).
The E2F1 internal deletion mutants: D253–258,their ability to transactivate certain genes.
D265–270, D271–276, D283–290, and D291–297 were
generated by in vitro site-directed loop out mutagenesisMATERIALS AND METHODS
of single-strand DNA prepared from pRcCMV HA-E2F1.
Cell culture and transfection
The HindIII/Eco47III E2F1 cDNA fragments from each
of these plasmids were then replaced with the HindIII-The human osteogenic sarcoma cell lines, U2OS or
SAOS2, were grown at 377 in Dulbecco’s modified Eagle Eco47III E2F1 cDNA fragment from pcDNA HA-E2F1
bHLHZ (Krek et al., 1993). The resulting plasmids encodemedium (DMEM) plus 10% fetal clone serum (Hyclone)
in a humidified, 10% CO2-containing atmosphere. Cells E2F1 polypeptides which begin at amino acid 102.
The mutant pRcCMV HA-E2F1 D264–283 was createdwere 80% confluent in 100-mm dishes at the time of
calcium phosphate transfection (Chen and Okayama, by digesting pcDNA HA-E2F1 with BclI and BglII and
religating the backbone plasmid. This construct was then1987) and were refed with fresh media 4 hr prior to
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digested with HindIII/XbaI and subcloned into the vector scribed above. Following incubation with the E2 probe,
an aliquot was removed from the reaction mix and loadedpRcCMV (InVitrogen).
pcDNA-HA-E2F4 D15 was constructed by PCR amplifi- onto a nondenaturing gel. Next, a 400-fold-molar excess
of cold E2 oligonucleotide was added to the reactioncations of an E2F4 cDNA using oligonucleotides 935,636
(reaction A) and oligonucleotides 937,637 (reaction B). mixture. At 10-, 30-, and 60-minute intervals, aliquots
were removed from the reaction mix and loaded onto theThe PCR products were digested with BamHI / StuI
and StuI / EcoRI, respectively, and ligated, into running gel.
pcDNA-HA linearized with BamHI and EcoRI. This HA
Transactivation assaysE2F4 D15 cDNA was then excised as a HindIII/XbaI
U2OS cells were transfected, as described above, withfragment and subcloned into the vector pRcCMV (In-
5 mg of the pGL2 E2 promoter reporter plasmid, 2 mg ofVitrogen). The sequences of PCR products were veri-
pCMVbGal, 100 ng–2 mg each of the indicated E2F andfied by DNA sequencing.
E4 expression plasmids, and pBSK (Stratagene) carrierSequences of primers were as follows: 636; 5*-GGTGGA-
to a total of 24 mg DNA. Approximately 24 hr after theTCCGCGATGGCGGAGGCCGGG-3*, 637; 5*-GGGGAATTC-
removal of the calcium phosphate-DNA precipitates, theTCAGAGGTTGAGAACAGG-3*, 935; 5*-TGAGCTCCAGGC-
cells were washed once with PBS, scraped into 1 ml ofCTCCTTGTTCACGTACTTCTTCTGCCATTGAGACC-3*, 937;
PBS, pelleted by centrifugation for 5 min at 5000 g, and5*-AAGGAGGCCTGGAGCTCACC-3*.
resuspended in 200 ml of 0.1 M KHPO4/1 mM DTT. The
Gel retardation assay cells were lysed by three cycles of rapid freezing and
thawing. Extracts were clarified by centrifugation for 15
A 20-ml binding reaction contained 2 mg of sonicated
min at 15,000 g and assayed for luciferase and b-galac-
salmon sperm DNA and either 1–2 ml each of the indi-
tosidase activity as described previously (Krek et al.,
cated E2F and DP-1 35S-labeled in vitro translation prod-
1993).
uct(s) (T7 TNT coupled transcription/translation system,
Promega). Each reaction mixture contained 20 mM Cell labeling and immunoprecipitation
HEPES (pH 7.5), 50 mM KCl, 10 mM MgCl2 , 10% glycerol, U2OS cells were transfected with 8 mg each of the
0.5 mM DTT, 0.1% NP-40. Where indicated, a 100-fold- indicated expression plasmids. Approximately 24 hr after
molar excess of unlabeled E2F wild-type or mutant oligo- removal of the calcium phosphate-DNA precipitates the
nucleotide was added. After a 15-min incubation at 257, cells were washed once with PBS, once with methionine-
0.5 ng of the indicated 32P-end-labeled oligonucleotide free DMEM (GibcoBRL), and placed in 3 ml of methio-
and, where indicated, 2 ml of either E4 or E4D13/14 in nine-free DMEM for 30 min at 377. This media was then
vitro translate, 3 ml of anti-HA monoclonal antibody replaced with 3 ml methionine-free medium supple-
12CA5 (tissue culture supernatant; Boehringer Mann- mented with 0.25 mCi of 35S-translabel (DupontNEN) and
heim), 1 ml of anti-HA polyclonal antibody HA.11 (Babco), 2 mM glutamine. Four hours later the cells were washed
2 ml of anti-E4 monoclonal antibody M45 (a generous gift twice with ice-cold PBS and lysed by incubation in 1 ml
of Dr. Patrick Hearing), 1 ml anti-T7 monoclonal antibody of EBC lysis buffer (50 mM Tris–HCl (pH 8.0), 120 mM
(1 mg/ml; Novagen), or 2 ml of control antibody (PN116, NaCl, 0.5% NP-40, 1 mg/ml leupeptin, 1 mg/ml aprotinin,
an anti-Polyoma Large T hybridoma supernatant kindly 0.5 mM NaF, 0.5 mM Na3VO4 , and 0.5 mM phenylmethyl-provided by Dr. James DeCaprio) was added, and the sulfonyl fluoride) for 30 min with gentle rocking. Clarified
reaction was allowed to proceed for an additional 15 extracts were prepared by centrifugation for 15 min at
min. The reaction mixtures were separated electophoreti- 15,000 g at 47. Five-hundred microliters of extract was
cally on a 4% polyacrylamide gel in 0.251 TBE at 300 V. incubated with 50 ml of 12CA5 tissue culture supernatant
Gels were dried and exposed to film for 4–16 hr at 0707 and 25 ml of a 1:1 mixture of protein A–Sepharose/NETN
with intensifying screens. (0.5% NP-40, 20 mM Tris–HCl (pH 8.0), 100 mM NaCl,
and 1 mM EDTA) plus 4% BSA for 1 hr at 47 with gentle
Oligonucleotide probes
rocking. The immunoprecipitates were washed five times
with NETN, eluted by boiling in 50 ml of sample bufferE2 pro. WT: 5* GATCAGTTTTCGCGCTTAAATTTGAG-
(2% SDS, 10% glycerol, 0.01% Bromophenol Blue, 62.5AAAGGGCGCGAAACTAG 3*; MUT: 5* GATCAGTTTG-
mM Tris–HCl (pH 6.8), and 100 mM DTT), and resolvedCTCGCTTAAATTTGAGAAAGGGCGACCAACTAG.
by electrophoresis in 10% SDS–polyacrylamide gels. TheOne site mutant. 5* GATCAGTTTGCTCGCTTAAATTT-
gels were treated with Enhance (DuPont/NEN), dried,GAGAAAGGGCGCGAAACTAG 3*.
and exposed to X-Ray film at 0707.Altered spacing mutant. 5* GATCAGTTTTCGCGCTT-
AACGCGAAACTAG 3*.
RESULTSThe off-rate analysis was performed essentially as de-
scribed previously (Neill and Nevins, 1991). We have previously shown that a bacterially produced
GST-E4 fusion protein, immobilized and purified on gluta-Briefly, 80-ml binding reactions were prepared as de-
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thione sepharose, could bind to E2F1 obtained from could be specifically resupershifted by the addition of
anti-epitope antibodies (Fig. 1B, compare lanes 3 and 4crude cell extracts (Kaelin et al., 1992). A GST-E4 C-
terminal truncation mutant failed to bind to E2F1 in these to lanes 2 and 6) as well as by an anti-E4 monoclonal
antibody (Fig. 1B, lane 5). Since these experiments wereassays. This mutation, in the context of unfused E4, has
been shown previously to impair the ability of E4 to inter- performed using rabbit reticulocyte lysates, we could not
exclude that an additional cellular protein, provided byact with E2F (Neill and Nevins, 1991). When cell lysates
were prepared from cells transfected with an E2F1 ex- these lysates, contributed to E2F1–DP-1–E4 complex
formation. We therefore attempted these experiments us-pression plasmid, we failed to detect an increase in E2F1
binding to immobilized GST-E4 (data not shown). This ing E2F1 and DP-1 produced in wheat germ extracts.
Under these conditions, E2F1 and DP-1, with or withoutlatter observation suggested, among several possibilit-
ies, that another cellular protein might be limiting in these the addition of E4, failed to bind to the E2F sites in the
E2 promoter (data not shown). Thus, we cannot at theassays.
Recently it has been shown that E2F DNA binding present time exclude that an additional protein, or pro-
teins, contributes to stable complex formation betweenactivity in vivo likely requires heterodimer formation. In
particular, it has been shown that E2F1 forms heterodim- E2F1 and DP-1 or between E2F1–DP-1 heterodimers
and E4.ers with a second cellular protein called DP-1 (Bandara
et al., 1993; Helin et al., 1993; Huber et al., 1993; Krek et It has been previously suggested that two E4 mole-
cules bind to two E2F molecules bound to E2F doubleal., 1993). Heterodimerization with DP-1 increases the
affinity of E2F1 for DNA and for the product of the retino- sites having the correct orientation and spacing (Hardy
et al., 1989; Hardy and Shenk, 1989; Raychaudhuri et al.,blastoma gene (pRB) (Bandara et al., 1993; Helin et al.,
1993; Huber et al., 1993; Krek et al., 1993). This latter 1990). In particular, it appears that E4 preferentially binds
to E2F molecules bound to the two E2F sites containedobservation suggested the possibility that E4 binding to
E2F1 might be enhanced in the presence of a cellular within the E2 promoter. We therefore repeated these
assays using an E2 probe in which one of the E2F sitesprotein such as DP-1. We therefore attempted to develop
an in vitro E2F1/DP1/E4 binding assay. was mutated or in which the spacing between the two
E2F sites was altered (Fig. 1C, left and right panels, re-Human E2F1 and mouse DP-1 were translated in vitro
using rabbit reticulocyte lysate and tested for their ability spectively). Using these two probes, the addition of E4,
but not E4 D, led to a slight retardation of the E2F1–to bind to the E2F sites present in the adenovirus E2
promoter, as determined by gel-shift analyses (Fig. 1A). DP-1–DNA complexes. Similar results were previously
obtained by others using partially purified E2F and likelyIn keeping with earlier results, E2F1 alone bound weakly
to these sites, and DP-1 failed to bind above the back- reflect the formation of unstable complexes containing
one molecule of E4 and one E2F DNA-binding unit (Hu-ground level of E2F gel shift activity found in unpro-
grammed reticulocyte lysate (compare lanes 5 and 2 to ang and Hearing, 1989; Marton et al., 1990; Neill et al.,
1990; Raychaudhuri et al., 1990). These two probes failed,lane 1, open arrow). As anticipated, mixing the E2F1 and
DP-1 translates led to a synergistic increase in specific however, to support the formation of the more slowly
migrating complexes observed in Fig. 1A. In addition, E4E2F DNA binding (Fig. 1A, lane 8). Addition of the E4 ORF
6/7 protein, produced in reticulocyte lysate, produced a failed to interact efficiently with E2F1 bound to the two
overlapping E2F sites contained within the DHFR pro-‘‘supershift’’ of the E2F1–DP-1 complexes indicative of
the formation of a ternary complex of E4, E2F1, and DP- moter (data not shown).
Previous studies using partially purified components1 (lane 11, closed arrow). This slowly migrating species,
which in earlier studies was referred to as the induced suggested that E4 stabilized the binding of E2F to the
adenoviral E2 promoter (Hardy et al., 1989; Hardy andor viral-specific form of E2F, likely represents a complex
containing two E4 molecules and two E2F DNA-binding Shenk, 1989; Raychaudhuri et al., 1990). To determine
whether this activity could be measured using E2F1, DP1,units (here E2F1/DP-1 heterodimers). Note also that the
endogenous E2F activity present in the rabbit reticulocyte and E4 reticulocyte translates, we performed off-rate
analyses with the radiolabeled E2 probe used in Fig. 1A.lysate was likewise shifted by the addition of E4 (lane 3,
closed arrow). Addition of an E4 ORF 6/7 protein bearing E2F1/DP1 heterodimers rapidly (10 min) dissociated
from the E2 probe following the addition of cold competi-a C-terminal deletion mutation (E4 D13/14) had no effect
(lane 14). This activity is specific as determined by oligo- tor (Fig. 2, compare lanes 5 and 6), whereas the addition
of E4 gave rise to a complex which was still detectablenucleotide competition experiments (Fig. 1A, compare
lanes 12 and 13). Similar results were obtained using E4 60 min into the chase period (Fig. 2, lane 12). Thus,
as predicted based on earlier studies, E4 stabilized theproduced in bacteria (data not shown). The presence of
E2F1 and DP-1 in these complexes was demonstrated by binding of E2F1/DP1 to the E2 promoter.
In an attempt to identify the region, or regions, of E2F1repeating this experiment with E2F1 and DP-1 proteins
containing N-terminal HA and T7 epitope tags, respec- required for E4 binding, we repeated the gel-shift experi-
ments using a panel of specifically altered E2F1 proteinstively (Fig. 1B). Under these conditions, the E4 complex
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FIG. 1. E4 ORF 6/7 can bind to E2F1/DP-1 heterodimers in vitro (A). DP-1 in vitro translate (lanes 2–4), HA-E2F1 in vitro translate (lanes 5–7), or
both (lanes 8–14) were incubated in the presence or absence of a 100-fold-molar excess of an unlabeled oligonucleotide corresponding to the
two E2F sites found in the adenovirus E2 promoter [wild-type sites (lanes 9 and 12) or mutant sites (lanes 10 and 13)]. E4 ORF 6/7 (lanes 3, 6, 11–
13) or E4 ORF 6/7 D13/14 (lanes 4, 7, and 14) in vitro translate was then added along with end-labeled wild-type E2 oligonucleotide. Complexes
were separated by electrophoresis in a 4% nondenaturing acrylamide gel and detected by autoradiography. The open arrow indicates the specific
complex formed by E2F1/DP-1 heterodimers. The closed arrow indicates a specific complex which forms following the addition of wild-type E4 ORF
6/7 to E2F1/DP-1 (lane 11 and 13). This complex appears to correspond to the ‘‘induced’’ or ‘‘viral-specific’’ form of E2F described earlier and therefore
likely contains two molecules of E4 and two E2F1/DP-1 heterodimers, whereas the faster migrating species seen in these two lanes likely contains
one E4 molecule complexed with E2F1/DP-1. (B) HA-E2F1 and T7-DP-1 in vitro translate was incubated with end-labeled wild-type E2 oligonucleotide
in the presence (lanes 2–6) or absence (lane 1) of E4 ORF 6/7 in vitro translate along with antibodies directed against T7 (lane 3), HA (lane 4), E4
(lane 5), or polyoma large T (control, lane 6). Complexes were separated by electrophoresis in a 4% nondenaturing acrylamide gel and detected
by autoradiography. (C) Formation of the slower migrating E4/DP-1/E2F1 complex requires two E2F sites with the proper spacing. Gel-shift assays
were performed as in (A) using end-labeled E2 oligonucleotides in which one of the two E2F sites was mutated (left) or in which the spacing
between the two wild-type E2F sites was altered (right). Note the slight retardation of the E2F1/DP-1 complex following the addition of wild-type
E4 (lanes 4 and 6).
(Fig. 3A). Each of these E2F1 mutants gave rise to compa- residues 102–241 (Krek et al., 1993). In these experi-
ments the E2F1 protein and the DP-1 protein containedrable amounts of protein upon in vitro translation as de-
termined by autoradiography (data not shown). Note that N-terminal epitope tags (HA and T7, respectively) to facil-
itate the identification of the complexes derived from thewe could, with this assay, only study those E2F1 proteins
which retained the ability to heterodimerize with DP-1 exogenous E2F1 and DP-1 species. The open arrow indi-
cates the complex formed between the truncated inputand to bind to DNA. It has previously been shown that
the region of E2F1 required for these functions maps to E2F1 mutants and DP-1 (Fig. 4). This faster mobility com-
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marked box region must be largely intact for efficient
binding of E2F1 to E4.
Since each of the cloned E2F family members can bind
to DP-1 (Beijersbergen et al., 1994; Ginsberg et al., 1994;
Helin et al., 1993; Krek et al., 1993; La Thangue, 1994)
and contains a region with apparent homology to the
E2F1-marked box, we next asked whether E2F2, E2F3,
E2F4, and E2F5 could likewise bind to E4. Indeed, as
shown in Fig. 5, all bound to wild-type, but not mutant,
E4 in a manner similar to E2F1. A 15-residue deletion of
the E2F4-marked box gave rise to a mutant which could
bind to DP-1 and form a stable DNA-complex (Fig. 5A,
lane 5, and data not shown) but could no longer bind to
E4 (lane 14), again in keeping with the notion that the
E2F marked box region is essential for stable binding to
E4. Note that the faint supershifted band in Fig. 5A, lane
14, is due to the interaction of E4 with the endogenous
E2F activity present in unprogrammed rabbit reticulocyte
lysate (data not shown).FIG. 2. Stabilization of E2F1/DP1 binding to the adenoviral E2 pro-
moter probe by E4. An end-labeled wild-type E2 oligonucleotide corre- We next asked whether the integrity of the E2F-
sponding to the two E2F sites found in the adenovirus E2 promoter marked box was essential for the binding of E2F to E4
was incubated with unprogrammed reticulocyte lysate (lanes 1–4) or in vivo. In the first set of experiments, we utilized a
with HA-E2F1 and T7 DP-1 in vitro translates in the absence (lanes 5–
coimmunoprecipitation assay developed by Helin and8) or presence (lanes 9–12) of E4 ORF 6/7 in vitro translate. 10, 30, and
Harlow (Helin and Harlow, 1994). U20S osteosarcoma60 min following the addition of a 400-fold-molar excess of unlabeled E2
oligonucleotide aliquots were removed for gel-shift analysis as de- cells were transfected with mammalian expression
scribed in the legend of Fig 1. plasmids encoding murine DP-1, HA-tagged wt, or mu-
tant E2F1, with or without an expression plasmid encod-
ing either wt or mutant E4. The stability of each mutant
plex is dependent on input DP-1 as determined by the following transient transfection was comparable to wild-
presence of a supershifted complex (band indicated by type E2F1 as determined by anti-HA Western blot analy-
the asterisk) following the addition of a monoclonal anti- sis of whole cell extracts (data not shown). The cells
T7 antibody. An E2F1 protein containing residues 1–311 were then metabolically labeled with [35S]methionine,
was able to bind to wild-type, but not mutant, E4 in these lysed, and immunoprecipitated with an anti-HA mono-
assays with seemingly wild-type efficiency (Fig. 4A, com- clonal antibody. Comparable recovery of each of the HA-
pare closed arrow complex in lanes 8 and 9 to lanes 4 tagged E2F1 species was confirmed by anti-HA Western
and 5). Interaction with E4 was manifest as a decrease blot analysis (data not shown). Bound proteins were
in the intensity of the ‘free’ E2F complex (open arrow) and then analyzed by protein gel electrophoresis followed
the presence of a supershifted complex (closed arrow). In by fluorography. As can be seen in Fig. 6A, wt, but not
contrast, E2F1(1–283) failed to bind to E4 (Fig. 4A, com- mutant, E4, was coimmunoprecipitated with HA-wt E2F1
pare closed arrow complex in lanes 12 and 13), although (compare lane 3 to lane 4). The identification of the E4
this particular E2F1 mutant repeatedly bound to DNA band was confirmed by anti-E4 Western blot analysis
less well than wt E2F1. This latter mutation violates an (data not shown). In contrast, E4 did not associate with
E2F1 domain of unknown function which is highly con- HA-E2F1 D283 – 290 in this assay, in keeping with the
served among the various E2F species cloned to date in vitro data above (compare lane 6 to lane 3). The band
referred to as the marked box (Ginsberg et al., 1994; indicated by the asterisk is likely to be DP1 based on
Lees et al., 1993) (see Fig. 3). Additional E2F1-marked its mobility and absence in lane 1. In experiments per-
box deletion mutants were likewise unable to bind to E4 formed in parallel with a plasmid encoding T7 tagged
in these assays (Figs. 3A and 4B and data not shown). DP1, DP1 was found to coimmunoprecipitate with both
In the experiments shown in Fig. 4B, each of the E2F1 E2F1 and E2F1(D283 – 290) (data not shown). Additional
species tested (including ‘‘wt’’ E2F1) lacked residues 1– E2F1-marked box deletion mutants were likewise un-
101 so as to alter their migration relative to the complex able to bind to E4 in this assay (summarized in Fig. 3A).
formed by the E2F species present in unprogrammed Thus, the marked box must be largely intact for E2F1
reticulocyte lysate. Residues 1–101 are not required for to coimmunoprecipitate with E4.
efficient binding to E4, DP-1, or DNA under these condi- E4 is thought to enhance the ability of E2F to bind to
tions (Fig. 4B, see lanes 4 and 5). The results of these the E2 promoter and thus enhance its ability to regulate
E2 transcription (Marton et al., 1990; Neill et al., 1990;experiments, summarized in Fig. 3A, suggest that the
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FIG. 3. (A) Schematic of E2F1 mutants assayed for E4 binding. The top diagram represents the domain structure of wild-type E2F1. Directly below
this is a blow up of the E2F1-marked box, with the darker shaded area representing the 15 most highly conserved residues. The first four mutants
below the marked box diagram are truncated at the positions indicated. Below these truncation mutants are six mutants which contain small
deletions within the marked box. The column on the left indicates whether the mutants are able to bind to E4 in the gel mobility shift assay. A ‘‘/’’
indicates that the percentage of the corresponding E2F1/DP1 heterodimer supershifted by E4 ORF 6/7 was comparable to that observed with wild-
type E2F1, a ‘‘0’’ indicates that none of the corresponding E2F1 heterodimer was supershifted, and a ‘‘//0’’ indicates a measurable supershift by
E4 which was reproducibly less efficient than observed with wild-type E2F1 under the same binding and gel electrophoresis conditions. The column
on the right indicates whether the E2F1 mutants can bind to E4 in vivo as determined by coimmunoprecipitation. ND, not done. (B) Level of
conservation of the marked box among E2F family members. Black areas represent identity between residues, and shaded areas represent conserved
residues.
O’Connor and Hearing, 1991; Obert et al., 1994). To fur- mid, an E2 promoter-luciferase reporter, and either a
wild-type or mutant E4 expression plasmid. As antici-ther determine whether E4 could interact with E2F1 in
vivo, we transfected cells with an E2F1 expression plas- pated, E2F1 alone transactivated the E2 promoter (Fig.
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FIG. 4. Binding of E2F1 mutants to E4 ORF 6/7 in vitro. (A and B) Wild-type HA-E2F1 [(A) lanes 4–7], HA-E2F1 1–311 [(A) lanes 8–11], HA-E2F1
1– 283 [(A) lanes 12–15], ‘‘wild-type’’ HA E2F1 [(B) lanes 4–7), HA-E2F1 D283–290 [(B) lanes 8–11], or HA-E2F1 D264–283 [(B) lanes 12–15] in
vitro translates were incubated with T7-tagged DP-1 in vitro translate. E4 ORF 6/7 (lanes 2, 5, 9, and 13) in vitro translate was then added along
with end-labeled wild-type E2 oligonucleotide. In lanes 1–3, unprogrammed reticulocyte lysate was added to assess the level of endogenous E2F
activity. The open arrow in A indicates the formation of a complex of input truncated E2F1 and DP-1. The closed arrow in A indicates the formation
of a complex of input truncated E2F-1, DP-1, and E4 ORF 6/7. The presence of T7-tagged DP-1 in these complexes was confirmed by the addition
of anti-T7 antiserum (lanes 3, 7, 11, and 15). The T7 supershift complex is indicated by an asterisk. Each of the HA-E2F1 species studied in B lack
residues 1–101.
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6B). The ability of E2F1 to score positively in these assays
likely depends on the availability of endogenous DP ac-
tivity, although this remains to be formally proven. Cotran-
sfection of wild-type, but not mutant, E4, reproducibly
enhanced the ability of wt E2F1 to transactivate the E2
promoter. The level of transactivation obtained when
E2F1 is cotransfected with E4 is greater than the additive
values of either plasmid transfected alone. Similar results
have now been obtained by others (Bandara et al., 1994;
Cress et al., 1993; Helin and Harlow, 1994). In contrast,
cotransfection of wt E4 and either E2F1-marked box mu-
tants D283–290 or D264–283 failed to give rise to su-
pra-additive stimulation of the E2 promoter (Fig. 6B and
data not shown). Each of these E2F1 mutants, however,
retained the ability to bind to DNA in vivo, as determined
by gel-shift analysis (data not shown) and could activate
transcription from reporters bearing E2F-binding sites
(Fig. 6B and data not shown). These results, taken to-
gether, suggest that the marked box contributes to the
binding of E4 to E2F1 in vivo and in vitro.
DISCUSSION
Using both in vivo and in vitro assays, we have identi-
fied a region of E2F1 which is required for recognition by
the adenovirus E4 ORF 6/7 protein. This region, located
between the E2F1 DNA binding and transactivation do-
mains, has been previously identified by others as having
significant homology to similarly located regions found in
the other E2F family members. This apparent homology,
coupled with the lack of known function for this region,
has led to its designation as the ‘‘marked box’’ (Beijersb-
ergen et al., 1994; Ginsberg et al., 1994; Ivey-Hoyle et al.,
1993; Lees et al., 1993).
Using an electrophoretic mobility shift assay and re-
combinant E2F1, DP-1, and E4 ORF 6/7, we found that
the formation of a slowly migrating complex, previously
referred to as the virally induced form of E2F (which
is thought to contain two E2F molecules and two E4
molecules) was dependent upon the presence of two
E2F sites with the proper orientation and spacing (Hardy
FIG. 5. Binding of E2F family members to E4 ORF 6/7 in vitro. (A). et al., 1989; Hardy and Shenk, 1989; Raychaudhuri et al.,
HA-E2F1 (lanes 1, 6, and 7), HA-E2F2 (lanes 2, 8, and 9), HA-E2F3 1990). In particular, elimination of one of the two sites in
(lanes 3, 10, and 11), HA-E2F4 (lanes 4, 12, and 13), and HA-E2F4D15 the E2 promoter, or alteration of their spacing, led to the
(in which the most highly conserved region of the marked box has
formation of a complex, previously suggested to containbeen deleted) (lanes 5 and 14) in vitro translates were incubated with
one molecule of E2F and one molecule of E4, which wasDP-1 in vitro translate. E4 ORF 6/7 (lanes 6, 8, 10, 12, and 14) or E4
ORF 6/7 D13/14 (lanes 7, 9, 11, and 13) in vitro translate was then only slightly retarded in mobility relative to ‘‘free’’ E2F
added along with end-labeled wild-type E2 oligonucleotide. Complexes (Huang and Hearing, 1989; Marton et al., 1990; Neill et
were separated by electrophoresis in 4% nondenaturing acylamide gels al., 1990; Raychaudhuri et al., 1990). In addition, the bind-
and detected by autoradiography. The open arrows indicate the faster
ing of E2F1/DP1 heterodimers to the adenoviral E2 pro-migrating complex of the input E2F1. The closed arrows indicate the
moter was stabilized in the presence of E4. Thus, our in‘‘induced’’ form of E4/E2F1/DP-1. (B) The end-labeled E2 probe was
incubated with unprogrammed reticulocyte lysate alone (lane 2), with vitro assay faithfully recapitulated the results of others
HA-E2F5 in vitro translate alone (lane 3), with T7 DP1 translate alone obtained prior to the availability of recombinant E2F. Fur-
(lane 4), with E4 translate alone (lane 8), or with HA-E2F5 and T7 in thermore, the mapping data we obtained using the gel
vitro translates in the absence (lanes 5–7) or presence (9–13) of E4
mobility shift assay was corroborated by our results us-ORF 6/7 translate. Anti-HA (lanes 6 and 10), anti-T7 (lanes 7 and 11),
ing coimmunoprecipitation of HA-E2F1 and E4 ORF 6/7anti-E4 (lane 12), or anti-polyoma large T (lane 13) was also added
prior to gel-shift analysis as in A. from mammalian cell extracts.
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Other investigators have likewise attempted to map
the region (or regions) of E2F1 required for recognition
by E4 (Cress et al., 1993; Cress and Nevins, 1994; Fagan,
1994; Helin and Harlow, 1994; O’Connor and Hearing,
1994). Using an in vivo transactivation-based assay,
Cress and coworkers suggested that the E2F1 hydropho-
bic heptad repeat, as well as certain residues in its trans-
activation domain, might participate in E4 binding (Cress
et al., 1993). These investigators later, using a yeast two-
hybrid assay, determined that E4 bound to DP-1, but did
not bind to E2F1 (Cress and Nevins, 1994). It should be
noted that the GAL4 DNA-Binding domain (G4DBD)-E2F1
chimera used as ‘‘bait’’ lacked E2F1 residues 284–437
and thus lacked the marked box. These investigators
also, however, failed to see an interaction between a
GAL4 activation domain/full-length E2F1 chimera (G4AD-
E2F1) and G4DBD-E4, despite the fact that the former
could bind to G4DBD-DP-1.
In contrast, Fagan and coworkers, also using a yeast
two-hybrid approach, found that a serum response factor
DNA-binding domain (SRF)-E4 chimera could bind to an
E2F1-VP16 chimera provided E2F1 residues 331–342
and 409–426 were intact, in apparent disagreement with
our own results (Fagan, 1994).
Our results are, however, wholly consistent with two
recent reports. Helin and Harlow found that E2F-1 resi-
dues 375–437 were not required for E4 binding, whereas
residues between 284 and 358 were (Helin and Harlow,
1994). These investigators also noted a requirement for
DP-1 for recognition of E2F1 by E4. Likewise, O’Connor
and Hearing, using an electrophoretic mobility shift
assay similar to the one used here, found that E2F1 resi-
dues 313–437 were dispensible for E4 binding, whereas
the marked box was not. These investigators also identi-
fied a region of DP-1, separate from its DNA binding
domain, which contributed to recognition of E2F1/DP-1
complexes by E4 ORF 6/7 (O’Connor and Hearing, 1994).
The simplest interpretation of our results, together with
previously published data, is that (1) stable binding of E4
to E2F is influenced by sequences present in both E2F
and DP family members, (2) the marked box region found
in E2F family members contributes to the recognition of
E2F/DP heterodimers by E4, and (3) the yeast two-hybrid
assays performed to date may have detected interactions
between E4 and E2F/DP heterodimers which cannot beFIG. 6. An E2F1-marked box mutant fails to interact with E4 ORF 6/
7 in vivo (A). U2OS cells were mock transfected (lane 1) or transfected measured using more conventional, and probably less
with plasmids encoding DP-1 (lanes 2–7), E4 ORF 6/7 (lanes 3 and 6), sensitive, techniques such as coimmunoprecipitation or
E4 ORF 6/7 D13/14 (lanes 4 and 7), and either HA-E2F1 wild type gel-shift analysis. Recognition of E2F/DP heterodimers by
(lanes 2–4) or HA-E2F1 D 283 – 290 (lanes 5–7). The cells were then
E4 may also be influenced by the binding of the formermetabolically labeled with [35S]methionine, lysed, and immunoprecipi-
to DNA, although our results, as well as the results oftated using an anti-HA monoclonal antibody. Bound proteins were re-
solved by SDS–polyacrylamide gel electrophoresis and detected by
fluorography. Bands corresponding to E2F1 and E4 ORF 6/7 are indi-
cated by the arrows. The band indicated by the asterisk is likely to be (100 ng and 2 mg, respectively). 48 hr later, cell extracts were prepared
DP1 (see text). (B) U2OS Osteosarcoma cells in 100-mm dishes were and assayed for luciferase and b-galactosidase. Luciferase values
transfected, in duplicate, with 5 mg of a reporter plasmid containing were normalized for b-galactosidase activity and expressed relative to
the adenovirus E2 promoter upstream of a luciferase cDNA, 2 mg of the activity observed when cells were transfected with the reporter
pCMV-bgal, and, where indicated, E2F1 and/or E4 expression plasmids alone.
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others, might suggest that E4 can bind to E2F/DP hetero- E2F species to bind to certain canonical E2F sites, just
as the binding of E4 to E2F leads to a complex whichdimers in solution (Helin and Harlow, 1994; Obert et al.,
1994). The finding that a highly conserved region in the preferentially binds to the E2F sites in the E2 promoter.
E2F family members, coupled with DP sequences, contri-
butes to E4 binding might account for earlier studies which ACKNOWLEDGMENTS
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